Work

LBA2_PR: Osimertinib (AZD9291) in pre-treated pts with T790M-positive advanced NSCLC: updated Phase 1 (P1) and pooled Phase 2 (P2) results

Year: 2016

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/s1556-0864(16)30325-2

Authors: J. Yang, S.S. Ramalingam, P.A. Jänne, M. Cantarini, T. Mitsudomi

Institutions: National Taiwan University Hospital, Emory University, Winship Cancer Institute, Dana-Farber Cancer Institute, AstraZeneca (United Kingdom), Kindai University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2336745060

FWCI: 22.84

Cites:

Cited by: 97

Related to: 10